Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon

常敏之 (Min-Ji Charng)


  • 學歷
  • 經歷
    • - 迄今 臺北榮民總醫院 內科部心臟內科 主治醫師
    • - 國立陽明交通大學 醫學系 教授
  • 醫療專長
    1. 成人心臟內科 心臟分子生物學 Cardiac Molecular Biology 介入性心臟學 Invasive Cardiology
  • 證照
    中華民國內科醫學會 中華民國心臟學會 中華民國血脂學會 中華民國重症學會


  1. Li YH, Yeh HI, Jeng JS, Charng MJ. Comparison of the 2017 Taiwan Lipid Guidelines and the Western Lipid Guidelines for High Risk Patients. J Chin Med Assoc 2018;81:853-9.
  2. Huang CC, Charng MJClinical evaluation of evolocumab for the treatment of homozygous familial hypercholesterolemia in Chinese patients. Ther Clin Risk Manag 2019;15:1209-16.
  3. Blom DJ, Harada-Shiba M, Rubba P, Gaudet D, Kastelein JJP, Charng MJ, Pordy R, Donahue S, Ali S, Dong Y, Khilla N, Banerjee P, Baccara-Dinet M, Rosenson RS. Efficacy and safety of alirocumab in adults with homozygous  familial hypercholesterolemia: The ODYSSEY HoFH trial. J Am Coll Cardiol 2020;76:131-142.
  4. Huang CC and Charng MJ. Genetic diagnosis of familial hypercholesterolemia in Asia. Front. Genet. 2020;11:833. doi: 10.3389/fgene.2020.00833.
  5. Huang CC, Niu DM, Charng MJ. Genetic analysis in a Taiwanese cohort of 750 index patients with clinically diagnosed familial hypercholesterolemia. J Atheroscler Thromb 2022;29:639-53.